R1	Has_value Arg1:T1 Arg2:T2	
R2	Has_value Arg1:T3 Arg2:T4	
R3	Has_value Arg1:T7 Arg2:T9	
R4	Has_value Arg1:T8 Arg2:T10	
R5	Has_value Arg1:T5 Arg2:T6	
R6	Has_qualifier Arg1:T12 Arg2:T13	
R7	AND Arg1:T12 Arg2:T5	
R8	Has_value Arg1:T14 Arg2:T15	
R9	Has_negation Arg1:T20 Arg2:T19	
R10	Has_qualifier Arg1:T17 Arg2:T18	
R11	Has_value Arg1:T22 Arg2:T23	
R12	Has_qualifier Arg1:T28 Arg2:T27	
R13	Has_temporal Arg1:T28 Arg2:T26	
R14	AND Arg1:T30 Arg2:T31	
R15	AND Arg1:T30 Arg2:T32	
R16	Has_negation Arg1:T30 Arg2:T29	
R17	AND Arg1:T28 Arg2:T30	
R18	Has_temporal Arg1:T34 Arg2:T33	
*	OR T35 T36
R19	AND Arg1:T12 Arg2:T7	
R20	AND Arg1:T12 Arg2:T8	
R21	Has_qualifier Arg1:T17 Arg2:T20	
T1	Person 0 11	Patient age
T2	Value 12 23	>= 18 years
T3	Measurement 25 50	Zubrod performance status
T4	Value 54 57	0-3
T5	Measurement 59 60	T
T6	Value 60 63	1-3
T7	Measurement 64 65	N
T8	Measurement 67 68	M
T9	Value 65 66	0
T10	Value 68 69	0
T12	Condition 70 84	adenocarcinoma
T13	Qualifier 92 100	prostate
T14	Measurement 102 117	Prostate volume
T15	Value 118 126	= 100 cc
T16	Informed_consent 128 162	Signed study-specific consent form
T17	Condition 164 188	Extension of local tumor
T18	Qualifier 200 215	adjacent organs
T19	Negation 216 226	other than
T20	Qualifier 227 243	seminal vesicles
T22	Measurement 250 265	Prostate volume
T23	Value 266 274	> 100 cc
T24	Condition 276 293	Nodal involvement
T25	Condition 295 313	Metastatic disease
T26	Temporal 315 320	Prior
T27	Qualifier 321 327	pelvic
T28	Procedure 328 340	radiotherapy
T29	Negation 341 347	except
T30	Procedure 359 378	combination therapy
T31	Condition 383 399	prostate cancer
T32	Condition 383 398	prostate cancer
T33	Temporal 400 407	History
T34	Condition 411 422	scleroderma
T35	Condition 438 449;463 471	psychiatric disorder
T36	Condition 453 471	addictive disorder
